MCKINZIE NUSS: Open Payments
NPI 1700446192 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,956 in 96 payments from 22 companies in 2025. Trend: 2023 $1,301 · 2024 $2,310 · 2025 $1,956
Food & beverage: $1,956
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $463 |
| GlaxoSmithKline, LLC. | 20 | $282 |
| Inspire Medical Systems, Inc. | 14 | $214 |
| HARMONY BIOSCIENCES LLC | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 6 | $117 |
| United Therapeutics Corporation | 6 | $109 |
| ABBVIE INC. | 5 | $99 |
| Baxter Healthcare | 4 | $97 |
| Mallinckrodt Hospital Products Inc. | 3 | $57 |
| PFIZER INC. | 3 | $57 |
Products named: AIRSUPRA, INSPIRE, NUCALA, FASENRA, WAKIX, DUPIXENT, TRELEGY ELLIPTA, Tyvaso.
Industry payments across ND — which companies pay providers there.
